Global Genetic Toxicology Market Growth (Status and Outlook) 2023-2029

Global Genetic Toxicology Market Growth (Status and Outlook) 2023-2029

LPI (LP Information)' newest research report, the “Genetic Toxicology Industry Forecast” looks at past sales and reviews total world Genetic Toxicology sales in 2022, providing a comprehensive analysis by region and market sector of projected Genetic Toxicology sales for 2023 through 2029. With Genetic Toxicology sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Genetic Toxicology industry.

This Insight Report provides a comprehensive analysis of the global Genetic Toxicology landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Genetic Toxicology portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Genetic Toxicology market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Genetic Toxicology and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Genetic Toxicology.

The global Genetic Toxicology market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Genetic Toxicology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Genetic Toxicology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Genetic Toxicology is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Genetic Toxicology players cover Frontage Laboratories, Accelera, Charles River, Pharmaron, Labcorp, Syngene, Vivotecnia, Technics and Aurigene Pharmaceutical Services, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Genetic Toxicology market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Genotoxicity Screening Assays
GLP Standard Genotoxicity Assays

Segmentation by application
Mini Ames/Ames
Gene Mutation
In Vitro Micronucleus
Chromosome Aberration
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Frontage Laboratories
Accelera
Charles River
Pharmaron
Labcorp
Syngene
Vivotecnia
Technics
Aurigene Pharmaceutical Services
ERBC Group
NextGen
Cardinal Health
Toxys
Abbott Toxicology
Evotec
EPL

Please note: The report will take approximately 2 business days to prepare and deliver.